Condition

Mitochondrial Dysfunction

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common interventions8

Lead sponsors shown3

Clinical trials

3 shown

In Vivo Investigation on Mitochondrial Dysfunction in Post-COVID Fatigue and Cancer Fatigue.NCT05753228 · 2022-12-09

UNKNOWN

Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic SuppressionNCT01194856 · 2010-10-01

TERMINATED

Intensive Exercise to Improve Mitochondrial Dysfunction in Pediatric ObesityNCT00962806 · 2009-08-01

UNKNOWN

Common interventions

Atazanavir/ritonavirDRUG1 Chalder Fatigue ScaleOTHER1 EfavirenzDRUG1 ExerciseBEHAVIORAL1 Hamilton Depression Rating ScaleOTHER1 Health Questionnaire (EQ-5D-5L)OTHER1 Lifestyle counselingBEHAVIORAL1 MRI/ 3D Arterial Spin Labelling (ASL) and 1H magnetic resonance spectroscopy (MRS)OTHER1

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

efavirenz1

Leading sponsors

Massachusetts General Hospital 1 National University Hospital, Singapore 1 The Cleveland Clinic 1

Trial status mix

UNKNOWN2

TERMINATED1

Phase mix

NA2

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.